ROKA - Roka Bioscience, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.62
-0.15 (-8.47%)
As of 11:01AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.77
Open1.76
Bid1.65 x 13500
Ask1.66 x 4000
Day's Range1.62 - 1.76
52 Week Range0.66 - 7.22
Volume358,969
Avg. Volume839,446
Market Cap8.11M
Beta1.81
PE Ratio (TTM)-0.13
EPS (TTM)-12.58
Earnings DateMay 4, 2017 - May 8, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
Trade prices are not sourced from all markets
  • Roka Bioscience, Inc. :ROKA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube2 months ago

    Roka Bioscience, Inc. :ROKA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Roka Bioscience, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Roka Bioscience, Inc. – CONMED Corporation and PerkinElmer, Inc. (CNMD-US and PKI-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 2.14 million, Net ... Read more (Read more...)

  • PR Newswire2 months ago

    Roka Bioscience, Inc. Agrees to Sell its Assets to Subsidiary of Institute for Environmental Health, Inc.

    WARREN, N.J., Aug. 17, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today announced that it has entered into an asset purchase agreement with Rokabio, Inc., a newly formed, wholly-owned subsidiary of Institute for Environmental Health, Inc. ("IEH"), for the sale of substantially all of the assets of Roka Bioscience in an all-cash transaction for an aggregate purchase price of $17.5 million, subject to certain adjustments set forth in the asset purchase agreement.  IEH's focus is to provide comprehensive risk management services to the food industry. The closing of the transactions contemplated by the asset purchase agreement is subject to certain customary conditions, including the receipt of consent of Roka Bioscience's lender and approval by the stockholders of Roka Bioscience of the transactions contemplated by the asset purchase agreement.  As part of the transaction, Roka Bioscience will be required to make a $2.5 million milestone payment pursuant to its license agreement.  The asset sale is the initial step in a contemplated liquidation of Roka Bioscience.

  • PR Newswire3 months ago

    Roka Bioscience to Co-Present Industry Webinar - Game of Zones: A Practical Guide to Listeria Monitoring and Detection

    WARREN, N.J., July 26, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens will host and present a free, informative webinar titled "Game of Zones: A Practical Guide to Listeria Monitoring and Detection" with guest speaker Dr. Virginia Deibel from Covance. When is Listeria reasonably likely to occur? Dr. Virginia Deibel, Director of Microbiology at Covance, will be presenting "Taking the Fuzzy out of Logic" which will provide an example driven guide that can serve as a template for food processors in the development and execution of Listeria monitoring programs.

  • PR Newswire3 months ago

    Roka Bioscience Announces AOAC Certification for 18-hour Sample Enrichment using ActeroTM ELITE Listeria Enrichment Media and the Atlas® Listeria Environmental Assay

    WARREN, N.J. , July 11, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), is very pleased to announce it has received the prestigious AOAC Performance Tested Methods SM certification from the ...

  • Business Wire3 months ago

    PURE Bioscience Announces Co-Marketing and Supply Agreement with Roka Bioscience, Inc.

    PURE Bioscience, Inc. , creator of the patented non-toxic silver dihydrogen citrate antimicrobial, today announced that it has entered into a two-year nonexclusive supply agreement with Roka Bioscience, Inc.

  • PR Newswire3 months ago

    Roka Bioscience, Inc. Announces Co-Marketing and Supply Agreement with PURE Bioscience

    WARREN, N.J. , July 10, 2017 /PRNewswire/ -- Roka Bioscience, Inc. ("Roka") (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of ...

  • PR Newswire3 months ago

    Roka Bioscience to Present at the International Association of Food Protection Conference

    WARREN, N.J. , July 7, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA) will be participating and presenting at the 2017 International Association for Food Protection (IAFP) Conference. The conference ...

  • PR Newswire4 months ago

    Roka Bioscience to Co-Present Industry Webinar

    WARREN, N.J., June 26, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens will host and present, along with Primus Laboratories, an informative webcast titled "Food Safety Pixels to Pictures: How to Bring your Data to Life". The webcast speakers will include Dr. Erin Dreyling, Vice President of Research and Scientific Affairs at Roka Bioscience, who will discuss how making the jump to molecular technology can elevate a pathogen control program.

  • PR Newswire4 months ago

    Roka Bioscience to Present at the 2017 MARCUM MICROCAP CONFERENCE

    WARREN, N.J., June 9, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens,  ...

  • Roka Bioscience, Inc. :ROKA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
    Capital Cube5 months ago

    Roka Bioscience, Inc. :ROKA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Roka Bioscience, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Roka Bioscience, Inc. – CONMED Corporation and PerkinElmer, Inc. (CNMD-US and PKI-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 2.04 million, Net ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of ROKA earnings conference call or presentation 11-May-17 8:30pm GMT

    Q1 2017 Roka Bioscience Inc Earnings Call

  • PR Newswire5 months ago

    Roka Bioscience Reports First Quarter 2017 Financial Results

    WARREN, N.J., May 11, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, ...

  • Accesswire5 months ago

    Investor Network: Roka Bioscience Inc to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 11, 2017 / Roka Bioscience Inc (NASDAQ: ROKA ) will be discussing their earnings results in their Q1 Earnings Call to be held May 11, 2017 at 4:30 PM Eastern Time. To listen ...

  • PR Newswire5 months ago

    Roka Bioscience, Inc. Announces Distribution Partnership with FoodChek Systems Inc.

    WARREN, N.J., May 8, 2017 /PRNewswire/ -- Roka Bioscience, Inc. ("Roka") (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne ...

  • PR Newswire6 months ago

    Roka Bioscience to Report First Quarter 2017 Financial Results on May 11, 2017

    WARREN, N.J., May 4, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, ...

  • PR Newswire6 months ago

    Roka Bioscience to Present and Exhibit at the 2017 Food Safety Summit

    WARREN, N.J., May 2, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens ...

  • PR Newswire6 months ago

    Roka Bioscience to participate in the 40th Annual National Food Policy Conference

    WARREN, N.J., April 10, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, ...

  • PR Newswire7 months ago

    Roka Bioscience to Present at the Sidoti & Company Spring 2017 Convention

    WARREN, N.J., March 27, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, ...

  • PR Newswire7 months ago

    Roka Bioscience to Present at the 29th Annual Roth Conference

    WARREN, N.J., March 10, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ:ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, ...

  • PR Newswire7 months ago

    Roka Bioscience Reports Fourth Quarter and Full Year 2016 Financial Results

    WARREN, N.J., March 9, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, ...

  • PR Newswire8 months ago

    Roka Bioscience to Report Fourth Quarter and Full Year 2016 Financial Results

    WARREN, N.J., March 2, 2017 /PRNewswire/ --   Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, ...

  • PR Newswire9 months ago

    Roka Bioscience To Exhibit And Present At IPPE 2017 Poultry Expo

    WARREN, N.J., Jan. 25, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens will be exhibiting and presenting at the International Production and Processing Expo. IPPE is the largest annual trade show for the poultry, meat and feed industries. Roka Bioscience will be exhibiting at booth B8168 and will also be presenting a TECH Talk on the topic of Effectiveness of Feed Interventions Strategies Thursday February 2nd at 11 -11:20 am in C1305.

  • PR Newswire9 months ago

    Roka Bioscience Announces Transition of CEO Role from Paul Thomas to Mary Duseau

    WARREN, N.J., Jan. 17, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens today announced the appointment of Mary Duseau as President and CEO.  Ms. Duseau succeeds Paul Thomas, the Company's President and CEO since 2009, who will assume the position as Chairman of the Company's Board of Directors.  The changes are effective today.

  • PR Newswire11 months ago

    Roka Bioscience Reports Third Quarter 2016 Financial Results

    WARREN, N.J., Nov. 7, 2016 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, ...